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A sequential study was carried out on maternal serum, fetal serum,
and amniotic fluid from 13-1/2 - 20-1/2 days of gestation. This study
was conducted to determine the regulatory role macromolecules such as
serum-like proteins in amniotic fluids played in homeostasis during
fetalogenesis. The total protein concentration in maternal serum
fluctuates throughout pregnancy. From 13-1/2 to 18-1/2 days of
gestation the total protein concentration exceeds that of non-pregnant
rat serum. As gestation advances total protein of amniotic fluid and
fetal serum also Increases. The total protein of the amniotic fluid
Increases from 0.095 g/100 ml on 13-1/2 days of gestation to a mean
high of 0.25 g/100 ml on 20-1/2 days of gestation. The total protein
of fetal serum in 13-1/2-day fetuses showed a mean of 0.403 g/100 ml.
The mean total protein in fetal rat serum increases to 2.4 g/100 ml
by day 20-1/2.
Albumin fractions in fetal serum and amniotic fluid represent
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more than 60% of the total protein, Densitometric scans show that as
many as 6 bands can be identified in the amniotic fluid and fetal serum
using Cyanogum-41 (polyacrylamide) gel electrophoresis. Large amounts
of prealbumin are present during most of the gestational periods in
the amniotic fluid and fetal serum. The amniotic fluid and fetal serum
are very similar. Sodium and potassium concentrations in the amniotic
fluid and maternal serum are very similar for the same gestation days.
Sodium and potassium concentrations in the fetal serum are greater than
that of maternal serum and amniotic fluid for 13-1/2 - 20-1/2 days of
gestation.
When maternal rats are subjected to dimethylsulfoxide (DMSO)
treatment, this apparent sequential change in blood serum and amniotic
fluid protein profiles is abolished. Observable electrolyte changes
in these compartmentalized fluids are also evident.
Gravid female rats injected on 14-1/2 days with 75% DMSO (0.25 ml)
show a decrease in the total protein of the maternal serum on 15-1/2
days of gestation. There is no apparent change in total protein con¬
centration on 19-1/2 days of gestation in the maternal serum. There
was no significant change in the total protein concentration of fetal
serum and amniotic fluid from DMSO-treated gravid rats. DMSO caused a
sharp decrease in the sodium levels in 15-1/2 and 19-1/2 day fetal
serum and amniotic fluid. The effect on potassium levels was negligible.
Thus, dimethylsulfoxide can Induce electrolyte disturbances and changes
in the concentration of proteins fractions in amniotic fluid and fetal
serum most drastically at 24 hrs post-treatment.
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Amniotic fluid is a transient liquid of uncertain status. It
begins to appear with the formation of the extra-embryonic membranes,
reaches a maximum in most species somewhat prior to the end of gesta¬
tion, and is dissipated at parturition. Obvious functions of amniotic
fluid are to provide thermal insulation, to cushion the embryo from
shock and from abrasion by the uterine wall, and to provide a spacious
moist environment in which the embryo can develop and move about in
relative weightlessness. More subtle functions of amniotic fluid such
as nourishment and regulation of fetal hydration or hydration remain
an enigma (Harvey, 1972). Because of the amnion's limited duration,
regulation of change in its fluid volume and contents remains un¬
accounted for by its generally related function.
Most of the chemical constituents of maternal and fetal plasma
are probably demonstrable in the amniotic fluid, and the study of its
relative concentrations plays an important part in understanding the
physiology of gestation. The postulation above is tangibly fortified
by studies of amniotic fluid which have permitted the prenatal pre¬
diction of the fetal condition in the various diseases which complicate
pregnancies and induce fetal anomalies.
Studies by Brzezinski et al. (1961) in human beings showed a
similarity in the electrophoretic pattern of amniotic fluid and fetal
serum and also showed that at term, larger differences existed in the
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relative concentrations of protein components when maternal serum and
amniotic fluid were compared.
The specific nature of the proteins found in the amniotic fluid
should provide information as to their source. Unfortunately, the
various studies on this problem are not in total agreement. McKay
et al. (1958) suggested that amniotic fluid during early human pregnancy
has the general protein structure of maternal interstitial fluids which
are, presumably, dilute dlalysates of maternal serum. In support of
this, Abbas and Tovey (1960) demonstrated the similarity of electro¬
phoretic patterns of amniotic fluid proteins and those of maternal serum
which had been dialyzed across fetal membranes.
In medicine, DMSO has been shown to cross the dermal barrier and
in high concentrations. It accomplished this with little or no perman¬
ent tissue damage (Klllgman, 1965). Lysozyme, as an exemplary protein,
has been shown to assume a configuration, when suspended in DMSO, with
greater flexibility than the native protein without change in its
molecular weight (Hamaguchl, 1964). It was observed in these studies
that the major configurational changes occurred with DMSO concentrations
between 60 to 70%. In blood serum proteins, it was suggested that
because of its comparatively small size DMSO is able to penetrate
regions on the albumin subunit Interfaces more readily than ethylene
glycol, polyethylene glycol, glycerol, and sucrose (Herskovits and
Laskowshi, 1962).
The objectives of this research were; (a) to determine the sequen¬
tial changes and comparative differences that occur in protein compo¬
sition of maternal serum, amniotic fluid and fetal serum during the
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gestational periods of 13-1/2 - 20-1/2 days; (b) to advance the knowledge
of the sequential and varied changes in the osmotic pressure in the
amniotic fluid occurring during rat fetalogenesls (McMillan, 1971);
(c) to determine the physiological role of macromolecular changes in
amniotic fluid by experimentally inducing fluid and electrolyte imbalan¬
ces using DMSO; and (d) to provide data which will elucidate the origin
of the amniotic fluid and its physiological role in maintaining a
homeostatic environment during fetalogenesls.
CHAPTER II
REVIEW OF LITERATURE
Origin and Composition of Maternal Serum and Amniotlc Fluid
Vosburgh et al. (1948) showed what appears to be important evidence
that water in the amniotic fluid is replaced from maternal plasma every
2.9 hrs. It was assumed that an equal amount of water is transferred
in the opposite direction, from the amniotic fluid to mother, thus
producing a continuous exchange of water between these two compartments.
Rosa (1951) found evidence of secretory potentialities in amniotic
epithelium. Hutchinson et al. (1955) utilized transfer rates of sodium,
potassium, and hydrogen Isotope tracers to find that amniotic fluid was
not a "transudate or dialysate of maternal plasma", but that each
element exchanged at its own rate and was in dynamic equilibrium with
the maternal system.
According to McKay et al. (1958), the general protein composition
of fluids from the embryonic side of the trophoblast resembled the
protein composition of maternal serum. In general, there appears to
be a lower relative concentration of all globulins in chorionic fluid
and amniotic fluid than in maternal serum. The differences in relative
ratios of beta and gamma globulin were too slight to be of any signifi¬
cance. These investigators suggested the possibility that proteins
from the embryonic fluids are derived from maternal serum by transfer
across the trophoblast. The fluids have a slightly higher albumin and
globulin ratio than serum and in this respect resemble other inter¬
stitial fluids of the adult such as lymph and ascitic fluids, which are
4
5
presumably dilute dialysates of serum.
From the similarities in protein patterns, Brzezinski (1961) con¬
sidered the possibility of fetal circulation supplies proteins to the
amnlotic fluid. Absence of large protein molecules in amniotic fluid,
such as lipoproteins and fribrinogen, and a reduction of gamma globulins,
clearly indicated that proteins of the pools serving as sources of
amniotic fluid undergo sequestration, perhaps by filtration or diffusion.
In this respect the amniotic fluid proteins appear similar in compo¬
sition to other interstitial fluids. The sequestered components of
amniotic fluid nevertheless show much resemblance in distribution to
that of fetal serum. Abbas and Tovey (1960) demonstrated the similarity
of electrophoretic patterns of amniotic fluid proteins and those of
maternal serum which had been dialyzed across fetal membranes. Despite
these observations, the general electrophoretic pattern of human amni¬
otic fluid proteins resembles that of cord serum rather than maternal
serum, leading Brzezinski et al. (1961) to question the possible maternal
origin of amniotic fluid proteins.
Usatequi-Gomez et al. (1966) showed, by a combination of acrylamide
disc electrophoresis and immunodiffusion, that the proteins of the
amniotic fluid originated at least partly from maternal serum. It was
found that haptoglobin 1-1 was present in all amniotic fluid derived
from mothers of this type, while it was absent in the corresponding
cord sera. Immunoglobulin A was also present only in amniotic fluid
and corresponding maternal sera and absent in cord sera. In addition
transferrin and ceruloplasmin values approximate those of the maternal
rather than those of fetal sera. It was shown in preliminary studies
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that any protein present in cord sera was absent in maternal sera and
amniotic fluid.
According to Usatequi-Gomez and Morgan (1968), one of the inter¬
esting protein groups in amniotic fluid is the group specific Gc protein
which is genetically determined. The mother and fetus were found to
belong to different Gc types. The Gc type of the amniotic fluid was
found to be similar to the maternal Gc type and thus showed that the
source of this protein was the maternal host. These findings, together
with previous work of the author, strongly suggested that all proteins
in the amniotic fluid are of maternal origin.
Rvoslahtl et al. (1966) also showed that the Gc protein of amniotic
fluid is obtained from the maternal circulation. Taken in conjunction
with previous investigators (Abbas and Tovey, 1960; Dancis et al., 1960;
Brambell et al., 1952) proved the fact that human placental lactogen
(HPL) cannot be detected in cord blood even though it is present in
amniotic fluid. These results confirm that most of the proteins in the
amniotic fluid are of maternal origin.
In human beings there are marked differences between the non¬
pregnant and maternal serum constitutions (Longsworth et al., 1945).
Maternal serum is characterized by decreased proportions of albumin and
gamma globulin and increased proportions of alpha and especially beta
globulin. The htaman fetal serum is much closer in composition to the
non-pregnant serum than to the maternal serum. Its most noticeable
discrepancy is in the decreased proportion of gamma globulin in fetal
as compared with the non-pregnant adult serum (Brambell et al., 1952).
Inspection of densitometer curves indicated higher proportions of
albumin to globulin for human beings in amniotic fluid and cord serum
than was found in maternal serum (30-42 weeks of gestation). One
draw-back was poor resolution of the alpha fraction in specimens of
amniotic fluid (Stander et al., 1964).
Moore et al. (1962) observed in human beings that the albumin of
maternal sera decreased during pregnancy, whereas alpha and beta
globulins, particularly beta globulin, increased greatly and gamma
globulin remained essentially unchanged. Almost the opposite condition
prevailed in the developing embryo. There was a marked rise in albumin
and gamma globulin but the alpha and beta globulins remained at the
same low level from three months to parturition.
When Brzezinskl et al. (1961) studied the electrophoretic distri¬
bution of proteins in amniotic fluid and in maternal and fetal serum
collected from 23 women during delivery, they found that the total
protein values were lower in amniotic fluid. The relative concentra¬
tion of albumin in the amniotic fluid was found to somewhat exceed that
in fetal serum and was markedly higher than in maternal serum. The
percentages of alpha and beta globulin fractions in fetal serum and
amniotic fluid were very close, but both were lower when compared with
maternal serum. On the other hand, they stated that the relative con¬
centration of gamma globulins in the amniotic fluid was markedly lower
than in fetal and maternal serum.
In amniotic fluid the alpha^^ globulin fraction appeared to account
for a somewhat larger proportion of total protein. However, it
followed the albumin zone so closely that it could not be separately
determined with sufficient accuracy.
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The concentration of beta-lipoprotein in the maternal serum was
elevated as compared with the non-pregnant controls and in the newly
born considerably decreased, as compared with the mother. No protein
bound lipids could be detected in the amniotic fluid even upon fifteen¬
fold concentrations (Brzezinski et al., 1961).
Total protein content of amniotic fluid in human beings was found
to be related to duration of gestation but was noted to be significantly
lower in patients in labor than those who were not in labor. The mean
total protein value for 15 patients who were in labor at the time
amniotic fluid was obtained was 0.23 gm/100 ml, as compared to 0.28
gm/100 ml for patients not in labor (Stander et al., 1964).
Brambell et al. (1952) observed that rabbit fetal serum (at 25
days of gestation) differs in several respects from that of the mother.
First, the total protein concentration was much lower, falling between
50 and 60% of that of the mother. Secondly, four components were dis¬
tinguishable in the fetal sera. The proportions in which these com¬
ponents occurred differ strikingly from those of the maternal sera, but
they may be taken to correspond to albumin, alpha, beta and gamma
globulins. The beta globulin constituted 43.6% of the total fetal
serum protein and only 16.1% of the total maternal serum protein. More¬
over, the beta globulins attained a higher absolute concentration
(11.1 mg/ml) in the fetal serum as compared to that of the maternal
serum (7.3 mg/ml). The albumin and gamma globulin were both relatively
and absolutely less in the fetal serum than in the maternal serum.
The amount of amniotic fluid during the gestation period of the
rat increased from the 12th to the 18th day of gestation. There was a
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decrease in the amount of amniotic fluid during the remaining 4 days of
the gestation period (Wirtschafter and Williams, 1957). The total
protein of amniotic fluid fluctuated throughout the entire period of
gestation. From the 18th day through the 22nd day of gestation, there
was a marked increase in all protein components. Unlike serum protein
levels, amniotic fluid contained a higher concentration of globulin
than albtimin until the 21st day of gestation. The albumin concentration
increases in greater proportion than the globulin from the 19th day on,
so that the concentration of albumin exceeds that of the globulin at the
end of the gestation period, the 22nd day (Wirtschafter, 1958).
Wirtschrafter and Williams (1957) have indicated that there is a higher
concentration of globulin than albumin in the amniotic fluid of rat until
the 21st day of gestation, at which time there is a reversal of this
ratio. Marsh et al. (1964) have also indicated that the albumin to
globulin ratio in amniotic fluid of rats increases during pregnancy.
Characterization of Amino-Acid Composition
Quantitative free amino acid levels of amniotic fluid, maternal and
fetal sera, and fetal urine were determined in 9 early human pregnancies.
Statistical analysis indicated a positive correlation between amino acid
levels in amniotic fluid with those in fetal serum and urine. These
data suggested that amniotic fluid and fetal seriam, in addition to
placental exchanges with fetal urine act as a diluent of amniotic fluid.
Analogous studies in 2 pregnancies indicated a higher turnover of amino
acids in maternal serum with a slower rate in amniotic fluid (A’Zary
et al., 1973).
Reid et al. (1971) quantitatively determined 21 amino acids in
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amniotic fluid and maternal plasma of 27 normal women at two periods of
normal gestation. The plasma levels of the 21 amino acids were also
determined for a group of normal non-pregnant adults. Significant
differences were found for levels of plasma amino acids in both 7 to
8-week and 36 to 40-week gestational groups as compared to the non¬
pregnant group. The free amino acid levels of amniotic fluid did not
reflect maternal plasma levels. Sixteen amniotic fluid amino acids were
significantly lower at 36 to 40 weeks than 14 to 18 weeks.
It was reported by Wirtschafter (1958) that free amino acids of
human amniotic fluid at full-term pregnancy showed species differences
and McKay et al. (1955) reported that the amino-nitrogen content of
human hydatldiform mole fluid was elevated over that of maternal plasma.
Kerr and Kennan (1969) found that in the rhesus monkey the total value
of 19 amino acids in the amniotic fluid decreased sequentially with
advancing gestational age. The same trend was seen for most of the
individual amino acids. A total value of 19 amino acids in maternal and
umbilical vein sera was also indicated. The value of fetal serum was
consistently elevated over those in both maternal serum and amniotic
fluid. The value of maternal serum showed a rapid decrease early in
pregnancy which stabilized by 75 days of gestational age. At this point
the value of amniotic fluid was comparable to that of the maternal serum.
Thereafter it was always below the value of both maternal and fetal sera.
Lesinski et al. (1967) also noted high levels of amino acids in the
blastocyst fluid of rabbits between the fifth and seventh days after
mating; shortly thereafter a noticeable drop occurred in the level of
most of the individual amino acids. Wirtschafter (1958) investigated
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amniotic fluid throughout the last 8 days of pregnancy in the rat, and
noted that amino acid levels rose with increasing gestation. He also
noted that several amino acids were found at higher levels in amniotic
fluid than in maternal blood.
DMSO: Its Metabolism and Teratological Implications
Most studies on the metabolism of DMSO have Indicated that
dimethyl sulfide and dimethyl sulfone are the end products of its
Interaction with other compounds in biological systems. Rammler and
Zaffaroni (1967) suggested that one of the chemical properties of DMSO,
namely, its ability to be oxidized, could be utilized "nonspecifically"
by cells. Ando (1957) demonstrated the ability of bacteria to reduce
DMSO to dimethyl sulfide under specific anaerobic conditions. Thus,
it can act as a source of oxygen. Also, Wong et al. (1971) found that
both man and miniature pigs transformed DMSO to dimethyl sulfone (DMSO2)
and dimethyl sulfide (DMS). Dimethyl sulfone was excreted in the urine,
whereas DMS was eliminated in the expired air. In man, the relative
amounts of DMS and DMSO2 in the plasma were similar to those found in
the urine.
Congenital abnormalities induced by DMSO have been reported in
mammals, amphibians, and birds. Ferm (1966) reported that DMSO Induced
gross congenital malformation in hamsters. Marln-Padllla (1966) found
that reduced ovulation in rats could be produced by DMSO administration.
They suggested that DMSO may have antagonistic effects on gonadotropin.
According to Hammerman (1966), DMSO inhibits larval involution and meta¬
morphosis in frogs. Caujolle (1965) and Browne (1968) reported terato¬
logical effects of DMSO in the chick. They found that injections of
50% DMSO induced limb bud blisters, allantoic congestion, blood blisters.
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blisters of the eyes, anophthalmia, micropthalmia, and coelosomia.
Fluid and electrolyte disturbances were also found in embryonic and
extra-embryonic compartments of chick embryo (Browne, 1968; 1970).
DimethyIsulfoxide: A Biomedical Tool for Analyzing
Changes in Amniotic Fluid Moiety
Dimethylsulfoxide (DMSO) had been shown to cross the dermal barrier
rapidly and in high concentration. It accomplished this with little
or no permanent tissue damage (Kiligman, 1965). It is not unreasonable
to assume that this visibly innocuous permeation of DMSO though a protein
barrier, is the result of reversible configurational changes of these
proteins because of water substitution by DMSO (Rammler and Zaffaronl,
1967). The enzyme, lysozyme, has been shown in DMSO to assume a con¬
figuration having greater flexibility than the native protein without any
change in the molecular weight (Hamaguchi, 1964). In these studies, it
was observed that the major configurational changes occurred with DMSO
concentrations between 60 to 70%. This effect was clearly shown in
rotatory dispersion studies with the enz3rme lysozyme. All of these
measured changes were completely reversible. In protein typographical
studies by different spectra (Herskovits and Laskowshi, 1962), solvent
induced shifts in the absorption maxima have been found. These shifts
in absorption maxima of amino acids such as tyrosine and tryptophan have
been attributed to changes in the special environment that surrounds
these groups in the native protein. The extent of these spectral
changes in different solvents is a measure of the exposure of these
groups in the protein to the solvent. In studies with lysozyme, there
is a gradual increase in the exposure of buried tryptophanyl residues
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with increased DMSO concentrations - this change increasing abruptly
again at 70% DMSO (Hamaguchi, 1964). The effectiveness of DMSO as a
spectral perturbant is related not only to its special chemical charac¬
teristic, but also to its size. In studies with bovine serum albumin
under carefully defined conditions, DMSO was a more effective perturbant
than ethylene glycol, polyethylene glycol, glycerol, and sucrose
(Herskovits and Laskowshi, 1962). Despite its difference in chemical
structure, these authors indicated that there was a correlation between
the size of the solvent and its effectiveness as a perturbant with
albumin. It was suggested that, because of its comparatively small
size, DMSO was able to penetrate regions of the protein subunits inter¬
faces more readily than the other bulkier solvents. This effect
depended upon the location of the chromophore and was not found for all
proteins (Williams et al., 1965).
Thus, DMSO appears to be extremely effective in altering the con¬
figuration of protein, and this change is apparently reversible with
several other enzymes (Rammler, 1966). Its effectiveness in this regard
appears to be related to its size (Earner, 1965) and capacity to sub¬
stitute for, or bind, water, in addition to affecting other hydrogen
bonded structures. These observations suggest a possible mode of action
of DMSO in the living system (Rammler and Zaffaroni, 1967).
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fetal-matched gravid rats and the cells and serum separated by collecting
the blood in mlcrofuge tubes and centrifuging for 10 min at 3000 rpm.
All separated amniotic fluid and blood serum was either prepared for
assay immediately or frozen until time of use. Some female rats were
injected intraperitoneally with 0.25 ml of 75% dimethylsulfoxide (DMSO)
on 14-1/2 days of gestation.
Electrophoretic Preparations and Analyses
Cellulose-acetate , microelectrophoresis
Gelman high resolution buffer (pH 8.8), Ponceau S, rinse solution
(5% acetic acid) and Sepra Clear solution were prepared and respective
trays were filled with 100 ml of each solution.
Sepraphore III (cellulose acetate strips) were submerged in Tris-
Barbltal Buffer (pH 8.8) and allowed to soak for at least 10 min. Fresh
buffer was then added to the Sepra-Tek electrophoretic chamber and the
buffer levels equalized in the two electrode compartments. The Sepra¬
phore III strips were removed from the buffer soaking tray and placed
on absorbent pads. Samples were immediately prepared for application
and applied to the etched areas on the sample wells with capillary
pipets. The applicator keys were then depressed in the samples for 15
sec, released and left in position.
The acetate strips were blotted on the absorbent pad lightly with
a second pad and carefully placed on the membrane frame assembly. The
loaded frame assembly was then placed in the chamber and immediately
covered. The loaded applicator was positioned on the chamber cover and
carefully, but firmly, keys were depressed. The keys were held in
contact with the membrane for approximately 20 sec and then released.
CHAPTER III
MATERIALS AND METHODS
Maternal serum, fetal serum, and amniotic fluid were acquired for
electrophoretic analysis and total protein determination by housing female
Long-Evans rats in proestrous with males of the same strain overnight.
The day of conception was determined by the vaginal smear technique.
This was done by removing the male rat from the cage of the female the
next morning and making vaginal smear preparations. The preparations
were then observed microscopically for sperm and, if present, this was
considered day 1/2 of conception. The pregnancy was then allowed to
continue until the day amniotic fluid and fetal serum were to be extracted.
On pre-determined days (13-1/2 - 20-1/2) amniotic fluid and fetal
serum were acquired from fetuses of gravid female rats by exposing them
to anesthesia with ethyl ether. While the rats were under anesthesia,
an incision was made into the abdominal wall, exposing the uteral horns,
which were subsequently excised.
Amniotic fluid was removed from the amniotic sac by aspirating the
fluid with a technique devised by Browne (1968). The samples were subse¬
quently centrifuged for 5 min to separate fluids and cellular debris.
The fetal blood was acquired by removing the chorionic and amniotic
membranes and puncturing the anterior cardinal veing: or neighboring
peripheral veins on the fetus. The blood samples were immediately centri¬
fuged for 10 min and the serum collected.
Maternal blood serum was acquired by heart-puncture from maternal
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The safety cap was immediately plugged onto electrodes, the power
supply turned on, and the voltage adjusted to 200. The samples were
electrophoresed for 30 min.
Immediately after the power was shut off from the electrophoretic
chamber, the acetate strips were carefully removed from the frame
assembly and floated onto the surface of Ponceau S in the staining tray.
When the strips were completely saturated with Ponceau S, they were
completely submerged and allowed to stain for 10 min. The Sepraphore
III strips were removed from the Ponceau S and placed in the first of
three rinse solutions and agitated. The strips were then taken through
two more consecutive trays of rinse solution until the background of
the strips was translucent.
The strips were removed from the final rinse tray and laid length¬
wise on glass slides, being careful not to trap air under the membranes.
A second glass slide was pulled lightly across the surface to remove
excess fluid. The ends of the strips were folded over the edge of
slides and the excess was trimmed, allowing approximately 1/4 of the
strip to overlap. The strips on the glass were placed in the Sepra Clear
solution and allowed to soak for 1-1/2 min. The strips were then removed
from the Sepra Clear and again excess fluids were removed with a second
slide. The slides were heated in a 90 C oven for 10 min so that the
background could become completely transparent. They were removed from
the oven and allowed to cool and the backs of the slides were cleaned
with alcohol. The slides were then read on a Digiscreen M scanning
densitometer (Gelman Instruments, Inc.), at 550 nm using a green filter.
The scanning results were recorded graphically on a Digiscreen Recorder.
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Cyanogum-41 gel electrophoresis
A Trls-Na2EDTA-Borate buffer (0.18 M), pH 8.4 was used as a electro-
phoresing medium. The gels were made up from a 5% cyanogum-41 (95%
acrylamide and 5% bisacrylamlde) solution. The cyanogum was dissolved
in the buffer and 0.1 ml of tetramethylethylenediamine (TMED) was added
for every 100 ml of gel solution. Immediately prior to pouring the gel
into the glass tubes, 100 mg of ammonium persulfate (AP) was added for
every 100 ml of gel solution to Induce rapid polymerization. About 2 ml
of this solution was Injected into 5 mm X 80 mm glass tubes in the
final preparation for receiving samples for electrophoresing. For
amnlotic fluid, maternal serum and fetal serum, 60, 2.5, and 10 micro¬
liters of sample were used, respectively. An equal volume of 40% sucrose
was mixed with each sample to Increase the density so that the sample
would settle evenly on top of the gel columns. A small amount of
bromophenol blue was added to each sample mixture to serve as a tracking
dye during the electrophoretic separation. The outer compartment of the
Gel Cell unit (Gelman Instruments, Inc.) was filled with 700 ml of buffer
and the inner tank was filled with 300 ml of buffer after the gel-con¬
taining tubes were put in the chamber. The sample mixture was added to
the tubes and the power supply current was set at 4 ma per tube.
Separation was continued until the tracking dye had migrated to the end
of the tubes, or for 2 hr 15 min. The gels were then removed from the
glass columns, put in test tubes and stained in 0.25% amido black lOB
made up in a methanol-water-acetic acid solution (5:5:1) for 30 min.
The gels were destained in 7% acetic acid. Gels were then quantitated




Preparatory tubes were labeled as reagent blank, standard, and
sample. To the reagent blank tube, 0.1 ml of total protein blank was
added; 0.1 ml of protein standard was added to the standard tube; and
to sample tubes 0.1 ml of sample was added. This was followed by the
addition of 5 ml of biuret reagent to all tubes. The solution was
mixed and allowed to stand for 15 min at room temperature (Sigma).
The tubes were then read on a Turner spectrophotometer at 540 nm using
the reagent blank as a reference source. Calculations were made using
the following formula (Gomall et 41.,, 1949).
A Sample
Serum Total Proteins (gm/100 ml) = X 8.0
A Standard
(in which A stands for absorbance)
Flame photometry
An Instrumentations Laboratories (IL) 343 Digital Flame-Photometer
was used for all sodium and potassium assays. The flame-photometer was
zeroed in with a lithium standard (4000 mEq/L) that was diluted twenty
times with deionized water. The instrument was standardized using IL
sodium and potassium standards (140 mEq/L and 5 mEq/L). In order to
determine the amounts of sodium and potassium in samples of maternal
serum, fetal serum, and amniotic fluid, 5 microliters of each were added
to 1 ml of diluted lithium blank and the samples were mixed and recorded




In the Long-Evans rat, we have observed that the total protein of
maternal serum fluctuates from days 13-1/2 - 20-1/2. It was observed
to be highest on day 14-1/2 (7.13 g/100 ml) and lowest on day 19-1/2
(5.86 g/100 ml) (Table 1, Fig. 1).
There was a gradual increase in the total protein of amniotic fluid
from day 13-1/2 - 20-1/2. The exception in this general pattern occurred
on day 15-1/2, wherein analysis showed a slight drop in the total
protein to 0.1029 g/100 ml on day 14-1/2 (Table 2). Likewise, that in
the blood serum of fetuses on 13-1/2 to 20-1/2 days of gestation there
was a gradual Increase in total protein. The total protein ranged from
0.402 g/100 ml on day 13-1/2 to 2.419 g/100 ml on day 20-1/2 of gesta¬
tion (Table 3). A graph showing the comparative changes in fetal serum
and amniotic fluid total protein is illustrated in Fig. 2.
Cellulose Acetate Electrophoresis
In an attempt to characterize the proteins in maternal serum, fetal
serum and amniotic fluid, electrophoresis was first carried out using
cellulose acetate strips. Electrophoresis was performed on fetal serum,
maternal serum, and amniotic fluid from 13-1/2 to 18-1/2 days of gesta¬
tion. In maternal serum we observed that during the overall fetal
gestation period there is only a very slight change in albumin concentra¬
tion as evidenced by comparison with blood serum from non-pregnant female
19
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Samples Mean S.D. Range
13-1/2 17 6.848 ±: .662 5.5 - 7.9
14-1/2 12 7.139 ± .62 6.4 - 8.3
15-1/2 13 7.044 ± .239 5.4 - 8.7
16-1/2 10 6.47 ± .238 6.7 - 6.2
17-1/2 12 6.506 ± .195 6.3 - 6.7
18-1/2 8 5.742 ± 1.16 5.0 - 6.79
19-1/2 10 5.86 ± .596 5.09 - 6.5
20-1/2 8 5.87 ± .209 5.6 - 6.1
Fig. 1 A graph showing changes in total protein of maternal




Table 2. Total protein changes in amniotic fluid of fetal rats




Samples Mean S.D. Range
13-1/2 13 0.09536 ± .0216 .062 - .114
14-1/2 13 0.113 ± .02816 .073 - .160
15-1/2 15 0.1029 ± .0304 .045 - .170
16-1/2 16 0.177 ± .0332 .145 - .200
17-1/2 11 0.1901 ± .0255 .160 - .237
18-1/2 17 0.2100 ± .400 .073 - .233
19-1/2 10 0.2306 ± .048 .189 - .305
20-1/2 8 0.2456 ± .090 .187 - .340
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Table 3. Total protein changes
20-1/2 of gestation.




Samples Mean S.D. Range
13-1/2 3 0.402 ± .233 .360 - .420
14-1/2 3 0.443 + .256 .364 - .490
15-1/2 5 0.547 + .250 .364 - .600
16-1/2 6 0.669 + .240 .547 - .672
n-m 10 1.048 + .235 1.016 - 1.36
18-1/2 8 1.495 + .235 1.226 - 1.6
19-1/2 10 2.415 + .9020 1.06 - 3.619
20-1/2 8 2.419 ± .611 1.846 - 3.2





rats (Table 4). The alpha-1 fraction of maternal blood serum, however,
gradually decreased during the 13-1/2 to 18-1/2 day period of fetal
gestation. The other three fractions, alpha-2, beta, and gamma,
fluctuated markedly during the same period (Table 4).
Analysis of the fetal serum showed that the prealbumin fraction did
not separate from the albumin fraction in samples from 13-1/2 - 15-1/2
day-old fetuses. However, the albumin concentration for these days was
higher than on days 16-1/2 - 18-1/2. There was a gradual decrease in
albumin fraction serum samples of fetal blood examined on 16-1/2 to 18-1/2
days of gestation. This decrease occurred concomitantly with a gradual
increase in the serum prealbumin fraction (Table 5). The percent of
globulins fluctuated during the gestation period. In particular, it was
noted that the gamma globulin was higher on 13-1/2 and 14-1/2 days of
gestation than at any other period (Table 5).
As for the amniotic fluid only two fractions, prealbumin and
albumin, could be determined with any degree of accuracy. Densltometric
scanning allowed for the detection of only traces of beta globulin. At
days 13-1/2, 16-1/2, and 18-1/2, over 50% of the protein in the amniotic
fluid was prealbumin and albumin (Table 6).
Gel Electrophoresis Analyses
The protein fractions in maternal serum fluctuated from 13-1/2 -
20-1/2 days of fetal gestation. There is very little change in the
albumin fraction which ranges from 31-32%. The remaining fractions
represented about 69% of the total protein (Table 7). These fractions
fluctuated comparatively more than the albumin fractions. During the
fetal gestational period nearly all of the maternal serum globulins are
26
Table 4. Summary of electrophoretic distribution of proteins in
maternal serum on cellulose acetate strip.*
Day Albumin Alpha-1 Alpha-2 Beta Gamma
13-1/2 44.6 9.3 15.15 20.8 9.7
14-1/2 39.8 12.3 15.9 19.6 12.4
15-1/2 40.0 12.0 16.0 19.0 13.0
16-1/2 45.0 10.2 17.9 18.9 7.6
17-1/2 42.5 9.9 19.9 17.4 10.5
18-1/2 41.2 10.0 19.5 19.9 9.6
NFS** 45.8 8.6 18.46 14.35 12.7
* Expressed in relative percentages; the sum of the total
fractions divided by each individual fraction multiplied by 100.
** NFS = Non-pregnant serum
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Table 5. Summary of electrophoretic distribution of proteins: iin fetal
serum on cellulose acetate strip.*
Day Prealbumin Albumin Alpha Beta Gamma
13-1/2 - 40.0 22.7 16.8 20.5
14-1/2 - 40.0 21,7 17.8 20.5
15-1/2 - 48.0 29.2 14.6 9.0
16-1/2 11,0 33.0 22.0 18.0 16.0
17-1/2 15.9 28.7 24.7 19.0 11.8
18-1/2 23.0 26.9 28.5 13.8 8.5
* Expressed in relative percentages.
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Table 6. Summary of electrophoretic distribution of proteins in
amniotic fluid on cellulose acetate strip.*
Day Prealbumin Albumin Alpha Beta Gamma
13-1/2 27.0 25.5 21.2 11,6 14.6
16-1/2 23.9 31.0 19.6 14.6 10.0
18-1/2 23.5 39.9 12.5 14.6 8.5
* Expressed as relative percentages.
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Table 7. Summary of densitometric analyses of maternal serum proteins from gel electrophoresis in relative percent.
Day Albumin Alpha-1 Alpha-■2 Alpha'-2l Transferrin Beta Gamma-1 Gamma--2
13-1/2 M. 31.0 8.4 8.0 12.8 13.0 12.2 14.6
S.D. ±2.4 ±1.1 ±1.4 ±1.3 ±2.2 ±2.3 ±2.0
R. 28.0 7.5 - 8.7 5.8 - 11.0 10.5 -15.0 10.0 - 17.0 9.5 - 16.5 12.6 - 20.0
14-1/2 M. 32.4 5.6 7.4 15,5 17.2 16.4 5.1
S.D. ±1.5 ±1.1 ±0.92 ±1.7 ±2.6 ±2.1 ±1.5
R. 30.4 - 34.1 4.2 - 8.1 6.0 - 8.5 9,0 - 18.53 10.0 - 20.0 14.1 - 20.8 3.0 - 8.3
15-1/2 M. 30.6 6.3 6.5 13.3 8.0 15.0 15.0 5.1
S.D. ±3.0 ±0.7 ±2.0 ±1.4 ±1.9 ±3.1 ±4.9 ±0.6
R. 26.5 - 35.0 5.0 - 7.4 4.6 - 10.5 12.0 - 16.0 6.0 - 12.0 10.0 - 18.6 14.6 - 20.6 4.5 - 6.0
16-1/2 M 32.7 5.3 6.3 10.8 6.4 19.0 14.8 5.0
S.D. ±2.9 ±1.2 ±1.2 ±1.5 ±1.9 ±1.7 ±2.2 ±2.1
R. 27.7 - 36.0 4.1 - 6.6 4.4 - 8.1 9.5 - 13.4 4.5 - 9.6 16.6 - 21.7 3.6 - 18.4 3.4 - 9.0
17-1/2 M. 30.0 4.6 5.8 10.8 5.5 18.7 19.0 5.6
S.D. ±2.5 ±0.8 ±0.6 ±1.1 ±0.6 ±3.8 ±1.9 ±0.4
R. 26.1 - 32.0 3.7 - 5.5 4.7 - 6.3 9.2 - 11,7 4.4 - 7.0 14.2 - 22.2 17.0 - 21.7 5.0 - 6.1
18-1/2 M. 31.2 5.5 8.5 9.6 16.3 16.8 4.0 8.1
S.D. ±2.6 ±1.1 ±1.2 ±1.8 ±4.1 ±1.4 ±1.2 ±1.3
R. 28.8 - 35.4 3.7 - 6.4 7.0 - 10.42 7.5 - 12.1 7.1 - 9.8 10.0 - 22.6 14.0 - 18.6 3.0 - 6.0
19-1/2 M. 32.0 6.6 -7.8 8.2 8.4 16.0 17.5 3.5
S.D. ±3.5 ±0.7 ±2,7 ±4.1 ±1.5 ±1.4 ±1.1 ±0.8
R. 29.0 - 35.8 4.6 - 6.2 5,4 - 11,0 6.0 -15.6 6,0 - 10.0 15.2 - 17.0 17.0 - 19.3 2.7 - 5.0
Table 7 (continued)
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Albumin Alpha-1 Alpha-2 Alpha-2^ Transferrin Beta Gamma-1 Gamma-2
20-1/2 M. 30.6 5.0 5.7 12.0 6.0 14.0 22.0 4.7
S.D. ±1.5 ±1.2 ±0,6 ±1.0 ±1.9 ±1.4 ±1.9 ±2.1
R. 30.4 - 34.1 4.1 - 6.7 4.7 - 6.3 10.5 - 14.5
. 4.5 - 9.6 12.0 - 16.0 19.0 - 23.0 3.4 - 8.0
NFS M. 32.0 4.7 4,8 11.9 6.6 19.1 16.0 4.9
S.D. ±3.6 ±1.7 ±1.1 ±1,8 ±1.2 ±0.5 ±1.5 ±0.7
R. 29.5 - 36.1 3.5 - 6.5 3,6 - 5,7 10.1 - 13.8 5.3 - 7.8 18.5 - 19.6 15.0 - 18.1 4.2 - 5.7
M = Mean
S.D. = Standard Deviation
R = Range
NFS = Non-pregnant serum
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elevated above those in the non-pregnant serum except for transferrin
(Table 7). Figure 3 shows a polyacrylamide gel profile and typical
densitometric scan of maternal serum on 19-1/2 days of gestation.
Figure 4 shows a polyacrylamide gel fraction profile and typical
densitometric analysis of fetal serum on 19-1/2 days of gestation. Six
bands are detected in fetal serum during this period of gestation. In
fetal serum the prealbumin fraction fluctuates from a high of 18% on
13-1/2 days to a low of 8.5% in the 14-1/2 day fetuses. Subsequently
in the 15-1/2 and 16-1/2 day fetuses this specific fraction (prealbumin)
Increases markedly to 13%, and in the 17-1/2 through 20-1/2 day fetuses
again there was exhibited a small but detectable fluctuation in concen¬
tration. In the 20-1/2 day fetuses prealbumin is highest (31%)(Table 8).
The albumin fraction was found to be at its lowest concentration in the
fetal serum of 20-1/2 day fetuses.
In the fetal rat blood serum the lowest alpha fraction concentration
was observed on days 17-1/2 and 18-1/2 of gestation. The lowest beta
fraction concentration was obtained on 17-1/2 days; the lowest gamma
fraction concentration on 13-1/2 days of gestation (Table 8). The
highest beta and gamma fraction concentrations occurred on the 14-1/2
day and the highest concentration of the alpha fractions in 19-1/2 day
fetal serum (Table 8). In Fig. 5 gel profiles are shown for 15-1/2 -
20-1/2 days fetal serum. As many as 8 bands could be separated in
fetal serum. We observed that in amniotic fluid of rat fetuses the con¬
centration of prealbumin and albumin fractions represented more than
50% of the total protein (Table 9). The albumin concentration fluctu¬
ated during the gestation periods from a low of 31.4% at 13-1/2 days






Fig. 4. Polyacrylamide gel profile and typical densitometric
scan of fetal serum on 19-1/2 days of gestation.
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Table 8. Electrophoretic distribution of proteinsin fetal blood sertim with gel electrophoresis.
Day Prealbumin Albumin Alpha Beta Gamma
13-1/2 M. 18.0 40.6 16.5 17.5 7.4
S.D. ±2.0 ±0.848 ±0.707 ±0.707 ±0.565
R. 17.0 - 19.0 40.0 41.0 16.0 1 o 18.0 - 17.0 7.0 - 7.8
14-1/2 M, 8.5 42.7 14.43 19,8 14.2
(jO
S.D. ±4,5 ±5,9 ±5,6 ±5,42 ±6,238
R. 7.0 - 13.6 37.3 - 47,3 8.6 - 17,0 15,0 - 25,7 10.0 - 21.4
15-1/2 M. 13.8 43.4 16,83 16,0 10,15
S.D, ±7.4 ±1,75 ±5,12 ±3.7 ±2,74
R. 13.0 - 23.0 40,8 - 44.8 14,0 - 20,0 10,8 - 19.6 8.2 - 14,2
16-1/2 M. 13,85 43.85 14.47 15,83 11,1
S.D. ±1,61 ±2,54 ±1,43 ±2.87 ±2.5
R. 12,0 - 15,4 40,0 - 45,0 12,6 - 16.0 13,0 - 19.3 9.0 - 13.5
17-1/2 M. 20.5 44.0 12,2 14.8 8,9
S.D. ±2.2 ±4,0 ±1,8 ±2.0 ±1.69
R. 18.3 - 23.3 38,0 - 46.7 12.5 - 14.0 12.5 - 17.1 7.8 -11.01.
Table 8 (continued)
Day Prealbumin Albumin Alpha Beta Gamma
18-1/2 M. 24.5 39.1 12.5 15.5 8.4
S.D. i2.0 ±1.08 ±2.2 ±0.204 ±0.048
R. 23.4 - 27.4 37.6 - 40.1 10.7 - 15.5 15.0 - 16.0 7.0 - 9.6
19-1/2 M. 23.1 31.2 17.8 16.3 11.7
S.D. ±2.2 ±6.2 ±3.5 ±0.986 ±2.06
R. 23.0 - 25.6 22.0 - 40.9 13.0 - 19.0 14.5 - 17.0 8.7 - 11.7'
20-1/2 M. 31.0 26.0 14.0 18.0 11.0
S.D. ±6.5 ±7.07 ±7.93 ±2.7 ±2.23
R. 27.0 - 36.2 21.0 - 31.0 7.9 - 18.0 15.8 - 20.8 9.2 - 13.5
* Expressed as relative percentage
M = Mean
S.D. = Standard Deviation
R = Range
Fig. 5 Polyacrylamide gel profiles of fetal serum for 15-1/2
20-1/2 days, respectively (A-F).
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Table 9. Acrylamide gel electrophoretic analyses of amniotic fluid protein fractions in relative percent.
Day Prealbumin Albumin Alpha Beta Gamma
13-1/2 M. 30.4 31.4 18.5 10.4 9.7
S.D. ±3.1 ±5.93 ±4.7 ±2.2 ±1.0
R. 27.4 - 33.6 26.4 - 38.0 7.3 - 10.0 9.0 -13.0 8.2
14-1/2 M. 19.5 41.5 15.7 12.7 10.6
S.D. ±4.6 ±2.4 ±5.9 ±2.1 ±2.1
R. 10.6 - 26.9 37.3 - 43.2 13.0 - 18.1 10.1 - 17.1 8.0
15-1/2 M. 20.6 33.6 17.6 13.5 14.7
S.D. ±3.3 ±6.2 ±2.7 ±1.7 ±2.5
R. 17.0 - 24.8 27.1 - 42.2 14.9 - 20.1 11.8 -15.1 11.0
16-1/2 M. 15.0 48.7 11.85 13.9 10.0
S.D. ±3.4 ±3.4 ±3.4 ±1.9 ±2.2
R. 9.9 - 21.0 46.2 - 51.9 8.4 - 18.8 11.0 - 15.5 8.1 - 13.3
Table 9 (continued)
Day Prealbumln Albumin Alpha Beta Gamma
17-1/2 M. 14.0 55.0 11.0 12.0 9.0
S.D. ±3.1 ±4.9 ±2.8 ±1.6 ±2.2
R. 8.7 - 19.2 49.8 - 55.9 7.7 -- 18.8 10.8 - 16.1 7.4 - 11.2
18-1/2 M. 14.5 51.5 8.7 12.5 12.8
S.D. ±1.6 ±7.7 ±1.3 +0.5 +1.1
00
R. 12.5 - 15.5 41.0 - 57.1 7.4 -■ 10.1 11.4 -12.5 9.7 - 11.1
19-1/2 M. 27.5 30.5 15.5 14.5 12.0
S.D. ±4.6 ±4.6 ±2.9 ±1.6 ±3.0
R. 23.5 - 33.0 24.0 - 35.0 12.7 -- 18.8 14.0 - 16.1 9.3 - 15.7
20-1/2 M. 34.2 31.2 7.8 16.8 10.0
S.D. ±2.8 ±0.1 ±0.7 ±1.4 ±0.3
R. 32.0 - 36.2 31.0 - 31.0 7.0 -■ 8.2 15.8 - 17.8 9.2 - 10.2
M. = Mean
S.D. = Standard Deviation
R. = Range
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to 55% on Yl-lll days, and then again decreases to approximately 31%
on day 20-1/2 (Table 9). The concentration of the alpha fraction is
lowest on 20-1/2 days; the beta fraction is lowest on 13-1/2 days, and
the gamma fraction is lowest on 17-1/2 days of gestation (Table 9).
Figure 6 shows a polyacrylamide profile and densltometric scan
of amniotic fluid proteins from 13-1/2 day-old fetuses. Six character¬
istic bands can be seen. Polyacrylamide gel profiles of protein in
amniotic fluid of 13-1/2 and 14-1/2 day-old fetuses are presented in
Fig. 7. Figure 8 shows a gel profile of amniotic fluid proteins from
15-1/2 - 20-1/2 day-old fetuses.
Sodium and Potassium Analyses of Fluids from Normal Rats
In the Long-Evans gravid rat we observed that blood serum sodium
concentration was highest on the 13-1/2 day of gestation (147.7 mEq/L)
and lowest on 19-1/2 days of gestation (125.5 mEq/L). The potassium
concentration in the same fluids was found to be highest on 20-1/2
days (6.45 mEq/L) and lowest on 17-1/2 days (3,9 mEq/L). In the non¬
pregnant serum the sodium concentration was 152.7 mEq/L (Table 10).
In fetal serum we found that at no time during the gestation
period (13-1/2 - 20-1/2 days) did the mean sodium concentration drop
below 140 mEq/L. Potassium on the other hand fluctuated markedly and
was lowest in 14-1/2-day fetal blood serum (13 mEq/L) (Table 11).
In the amniotic fluid of rat fetuses the sodium and potassium
concentrations were lower than those in the fetal serum (Table 12).
However, the highest concentration of sodivim was observed to be on
19-1/2 days of gestation (141 mEq/L); the lowest concentration (122
mEq/L) was on day 18-1/2 of gestation (Table 12). The highest potassium
Fig. 6 Polyacrylamide gel profile and typical densitometrlc
scan for amniotic fluid from 13-1/2 day-old fetuses.
 
Fig. 7. Polyacrylamide gel profiles of amniotic fluid for 13-1/2
days (A) and 14-1/2 days (B).
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Fig. 8. Polyacrylamide gel profiles of amniotic fluid for
15-1/2 - lO-lH days, respectively (A-F).
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Table 10. Concentrations of sodium and potassium in maternal blood
serum on 13-1/2 - 20-1/2 days of gestation.
Number
of
Day Samples Na"^ (mEq/L) (mEq/L)
13-1/2 17 Mean 147.7 6.1
S .D. * ±15 ±.79
Range 127.2 - 151.0 4.8 - 6.8
14-1/2 17 Mean 137.0 5.6
S.D. ±12 ±0.4
Range 120.0 - 159.0 5.2 - 6.9
15-1/2 10 Mean 135.0 5.6
S.D. ±10.9 ±0.4
Range 128.0 - 151.0 5.5 - 6.0
16-1/2 10 Mean 135.0 4.0
S.D. iLO iO.4
Range 112.4 - 144.0 3.4 - 4.6
17-1/2 10 Mean 131.8 3.9
S.D. ±7.9 ±0.4
Range 120.0 - 142.6 3.5 - 4.5
18-1/2 8 Mean 146.3 5.9
S.D. ±4.6 ±0.14
Range 143.0 - 149.0 5.8 - 6.0
19-1/2 10 Mean 125.5 5.7
S.D. ±6.7 ±0.7





Day Samples Na"*" (mEq/L) K*" (mEq/L)
20-1/2 8 Mean 127.9 6.45
S.D. ±0.07 ±0.2
Range 127.2 - 128.1 6.3 - 6.6
NSP** 10 Mean 152.7 6.2
S.D. ±5.32 ±0.6
Range 145.5 - 159.5 5.4 - 7.0
* S.D. = Standard Deviations
** NSP = Non-pregnant serum
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Table 11. Concentrations of sodium and potassium in 13-1/2 -
20-1/2 day old fetal serum.
Number
of
Day Samples Na+ (mEq/L)* (mEq/L)
13-1/2 8 Mean 144.0 17.2
S.D. ±5.8 ±1.7
Range 140.0 - 151.0 15.3
14-1/2 8 Mean 146.7 14.4
S.D. ±17.2 ±1.2
Range 123.0 - 164.0 13.1
15-1/2 10 Mean 160.0 18.86
S.D. ±17.1 ±1.59
Range 144.0 - 178.0 17.8
16-1/2 10 Mean 144.5 25.55
S.D. ±2.1 ±0.49
Range 143.0 - 146.0 25.5
17-1/2 10 Mean 155.0 20.0
S.D. ±10.0 ±2.7
Range 139.0 - 169.0 17.4
18-1/2 8 Mean 143.7 12,94
S.D. ±17.6 ±1,56












Samples Na"*' (mEq/L) K+ (mEq/L)
19-1/2 10 Mean 144.2 16.0
S.D. ±4.3 ±0.65
Range 130.0 - 155.0 15.0 - 16.8
20-1/2 8 Mean 142.8 15.9
S.D. ±8.16 ±0.64
Range 136.0 - 156.0 15.0 - 16.8
* = Concentrations measured in milliequivalents per liter (mEq/L)
S.D. = Standard Deviations
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Table 12. Concentrations of sodium and potassium in 13-1/2 - 20-1/2
day fetal amniotic fluid.
Number
of
Day Samples Na"^ ((mEq/D* K+ (mEq/L)
13-1/2 10 Mean 126.0 6.30
S.D. ±18.1 ±1.70
Range 107.0 - 156.1 3.9 - 8.7
14-1/2 10 Mean 123.4 4.6
S.D. ±12.7 ±1.7
Range 109.0 - 146.5 3.0 - 8.7
15-1/2 10 Mean 145.9 4.5
S.D. ±11.7 ±0.7
Range 137.7 - 158.6 3.1 - 5.4
16-1/2 10 Mean 134.1 3.9
S.D. ±12.0 ±0.4
Range 112.4 - 155.0 3.4 - 4.4
17-1/2 10 Mean 133.7 4.3
S.D. ±7.9 ±1.4
Range 120.0 - 140.6 3.5 - 4.5
18-1/2 10 Mean 122.1 4.4
S.D. ±10.2 ±0.9






Samples Na"^ (mEq/L)* (mEq/L)
19-1/2 10 Mean 141.4 4.5
S.D. ±10.5 ±0.3
Range 122.4 - 155.9 4.3 - 5.0
20-1/2 10 Mean 135.2 4.6
S.D. ±7.9 ±1.7
Range 120.0 - 140.6 3.0 - 8.7
* = Concentrations measured in milliequivalents per liter.
S.D. = Standard Deviations
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concentration was on 13-1/2 days (6.30 mEq/L); the lowest was on 16-1/2
days (3.9 mEq/L). There were no significant changes in potassium con¬
centrations from 14-1/2 - 20-1/2 days in studies on the amniotic fluid
of rat fetuses.
Analyses of the Effects of DMSO on Protein Concentrations
and Sodium and Potassium Levels in Maternal and
Fetal Blood Serum and Amniotic Fluid
Total protein
When gravid rats were injected with 0.25 ml of 50% DMSO on day
14-1/2, there was a decrease in the total projtein of maternal serum on
day 15-1/2 to 5.5 g/100 ml when compared with non-treated gravid rat
of 7.044 g/100 ml (Table 13). By day 19-1/2 the total protein was
5.6 g/100 ml, which is the same as that observed in the non-treated
gravid females on day 19-1/2 of gestation.
In the 15-1/2-day fetuses of maternal rats that had been injected
with DMSO, we observed that there was a slight decrease in the total
protein of fetal serum (0.0530 g/100 ml) and a marked decrease in
19-1/2 day fetal serum (2.415 g/100 ml) when compared with that of
untreated gravid female rats (Table 13). In the amniotic fluid of
fetuses from treated rats there is also a slight decrease in the total
protein when compared with the amniotic fluid of fetuses from untreated
rats. On 15-1/2 days of fetal gestation the total protein was 0.530
g/100 ml and 0.950 g/100 ml on day 19-1/2 (Table 13). Figures 9 and 10
show a comparison between maternal serum, fetal serum, and amniotic
fluid sodium and potassium concentrations from 13-1/2 - 20-1/2 days of
gestation.
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Table 13. Total protein changes in maternal serum, fetal serum, and




Samples Mean S.D. Range
15-1/2 MS 10 5.5 ±0.366 4.9 - 5.7
19-1/2 MS 10 5.80 ±0.137 5.6 - 5.9
15-1/2 FS 4 0.53 ±0.090 0.44 - 0.65
19-1/2 FS 8 1.88 ±1.050 0.91 - 3.60
15-1/2 AF 10 0.0950 ±0.043 0.42 - 0.17
19-1/2 AF 10 0.2142 ±0.106 0.25 - 0.06
MS = Maternal serum
FS = Fetal serum
AF = Amniotic fluid
Fig, 9. Comparison between maternal serum, fetal serum, and
amniotic fluid sodium concentrations for 13-1/2 -
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Fig. 10. Graph showing a comparison between maternal serum,
fetal serum, and amniotic fluid potassium levels for
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Gel-electrophoretlc analyses
When gravid females were injected with DMSO a gradual increase in
maternal serum protein fractions was observed, in particularly in the
alpha, transferrin and gamma fraction on day 15-1/2 of gestation.
On day 19-1/2 there was a marked increase in the albumin fraction of
the maternal serum to an average of 36%. In contrast the concentra¬
tions of alpha and beta fractions were lower in the DMSO-treated
gravid rats than in the untreated gravid ones (Table 14).
In DMSO-treated gravid female rats 60% of the protein in the
15-1/2-day fetal serum was albumin and in the amniotic fluid 67% was
albumin (Table 15). The prealbumin was lower in the blood serum of
untreated fetuses at 15-1/2 days (13.8%) than in the treated (20.2%),
and about the same in the untreated 19-1/2 day fetuses (23.1%) when
compared to the analyzed fractions treated for 19-1/2 day fetuses
(24.4%). In the amniotic fluid the prealbumin was higher in the
untreated animals.
Sodium and potassium analyses of fluids from DMSO-treated rats
When gravid rats were injected with DMSO on 14-1/2 days of
gestation the mean sodium concentrations in the maternal blood serum
were 135.4 mEq/L on 15-1/2 days and 126.7 mEq/L on 19-1/2 days of
gestation. The mean potassium concentrations were 5.3 and 5.5 mEq/L
for 15-1/2 and 19-1/2 days of gestation, respectively. These resulting
data were very close to those observed in untreated gravid female
blood serum (Table 16).
In blood serum of 15-1/2-day old fetuses of DMSO-treated maternal
hosts, the mean sodium concentrations were 150.0 mEq/L and 128.0 mEq/L
Table 14. Electrophoretic distribution of proteins in maternal serum of DMSO-treated rats in relative percent.*
Day Albumin Alpha-1 Alpha-2 Alpha-2^ Transferrin Beta Gamma-1 Gamma-2
15-1/2 M. 31.8 5.1 7.2 12.9 6.8 17.0 14.6 4.5
S.D. ±4.3 ±0.5 ±0.9 ±1.6 ±1.1 ±3.2 ±1.0 ±0.2
R. 28.5 - 36.7 4.6 - 5.5 6.4 - 8.3 10.9 - 14.0 5.4 - 7.5 14.2 - 20.7 13.8 - 15.8 4.0 - 4.5
19-1/2 M. 36.0 4.0 5.9 8.8 5.0 18.1 16.2 6.0
S.D. ±1.2 ±0.6 ±2,3 ±0.4 ±0.2 ±1.6 ±0.2 ±0.1
R. 35.2 - 37.1 3.7 - 4.5 4.2 - 7,5 8.5 - 9.1 4.9 - 5.3 17.0 - 19.3 16.0 - 16.1 6.0 - 6.1
* Expressed in percentage
M. = Mean
S.D. = Standard Deviations
R. = Range
Table 15. Electrophoretic distribution of serum and amniotic fluid proteins from fetuses of
DMSO-treated maternal rats in relative percent.*
Day
15-1/2 FS M. 20.2 40.4 16.5 16.8 6.1
S.D. ±5.2 ±0.848 ±0.707 ±0.986 ±0.56
R. 18.3 - 23.4 40.0 - 41.0 16.0 - 17.0 14.5 - 17.0 6.0 - 6.9
19-1/2 FS M. 24.4 34.9 16.8 15.1 8.8
S.D. ±0.9 ±3.7 ±1.3 ±3.9 ±0.66
R. 23.0 - 25.5 29.6 - 38.1 11.6 - 19.8 15.9 - 18.7 7.0 - 9.7
15-1/2 AF M. 15.0 52.7 10.0 14.2 8.1
S.D. ±2.0 ±2.6 ±2.1 ±2.0 ±1.3
R. 12.9 - 19.1 48.1 - 55.0 8.03 - 14.9 12.0 - 18.0 5.7 - 10.0
19-1/2 AF M. 16.8 50.5 12.3 11.6 8.8
S.D. ±4.4 ±5.2 ±3.6 ±1.7 ±1.9







. M = Mean
Amniotic fluid
S.D. = Standard Deviation R = Range
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Table 16. Concentrations of sodium and potassium in DMSO-treated
maternal serum, fetal serum, and amniotic fluid for
15-1/2 and 19-1/2 days of gestation.*
Samples
15-1/2 MS 10 M. 135.4 5.3
S.D. ±7.6 ±0.8
R. 120.0 - 147.0 4.0 - 6.5
19-1/2 MS 10 M. 126.7 5.5
S.D. ±3.6 ±0.7
R. 115.0 - 144.0 5.2 - 6.4
15-1/2 FS 6 M. 150.0 18.5
S.D. ±15.0 ±3.7
R. 131.0 - 176.0 12.0 - 23.8
19-1/2 FS 8 M. 128.0 15.9
S.D. ±14.5 ±3.9
R. 109.0 - 148.0 9.0 - 20.0
15-1/2 AF 10 M. 133.4 3.7
S.D. ±5.8 ±0.9
R. 120.0 - 139.9 3.1 - 4.2
19-1/2 AF 10 M. 126.0 4.7
S.D. ±14.0 ±0.4
R. 109,0 T. 146,0 3.8 - 4.7
*Concentrations measured in milliequivalents per liter.
MS = Maternal serum FS = Fetal serum AF = Amniotic fluid
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in 19-1/2-day old fetuses. The potassium blood serum concentrations
were 18.5 and 15.9 mEq/L for 15-1/2- and 19-1/2-day old fetuses,
respectively. These resulting concentrations were higher than those
observed in untreated animals in 15-1/2- and 19-1/2-day old fetuses
(Table 16). In the amniotic fluid of fetuses of DMSO-treated maternal
rats the mean sodium levels were 133.4 mEq/L on 15-1/2 days and 126.0
mEq/L on 19-1/2 days. The mean potassium levels were 5.3 mEq/L for





Of all known chemical compounds proteins are the most complex and
the most characteristic of living matter. Using the biuret method
(Gornall et al., 1949), we have conducted a comparative study of the
total protein of maternal serum, fetal serum and amniotic fluid, from
13-1/2 - 20-1/2 days of gestation in the Long-Evans rat. The study
reveals that there is constant fluctuation in the concentration of
proteins during these denoted periods of gestation.
In the maternal serum the concentration of the protein is not in
a steady state. The protein concentration fluctuates from a high of
7.1 g/100 ml on 14-1/2 and 15-1/2 days of gestation to a low of about
5.8 g/100 ml on days 18-1/2 - 20-1/2 of gestation. This fluctuation
in the total protein is probably due to the physiological changes that
the gravid females experience during the gestational period. On a whole,
the total protein concentration of maternal rat serum is higher than
that of non-pregnant rat serum (6.1 g/100 ml). In maternal rat serum
there is a higher concentration of globulins than albumin. This is in
opposition to the work of Wirtschafter and Williams(1957) whose results
show that there is a higher concentration of albumin than globulins in
the maternal serum of rats. Our data show that serum contains from
31-32% albumin. In human beings, albumin constitutes about 45% of the
total proteins at term (McKay et al., 1958; Viergivers et al., 1962).
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Also, Moore et al. (1962) reported that albumin in the maternal serum
decreased during pregnancy. In the Long-Evans rat, however, no
significant decrease in the albumin is noted with the gel or cellulose
acetate electrophoresis studies. The albumin fraction is in fact
higher in the cellulose acetate electrophoretic studies. We think
this is due to the fact that the cellulose acetate system did not give
the well-defined separations shown in the gel electrophoretic bands.
The alpha-1 and beta fractions are higher and the gamma fraction is
lower in the cellulose acetate plate studies than in the gel electro¬
phoretic studies. The alpha and beta globulins of maternal rat serum
are greatly increased over those of non-pregnant rat serum. This is
also the case in human beings (Moore et al., 1962).
The total protein for both amniotic fluid and fetal serum is
much lower than that of maternal serum. However, total protein values
are lowest in the amniotic fluid. It is markedly noticeable that the
prealbumin and albumin fractions are conspicuously unstable and continu¬
ously fluctuate during the entire gestation period. These fractions
represent from 55 to 65% of the total protein in the amniotic fluid.
The same conditions prevail in the fetal serum where 51 to 60% of the
total protein constituency is prealbumin and albumin. Wirtschafter and
Williams (1957) reported that by 22 days of gestation in the Long-Evans
rat, the albumin fraction represented more than 50% of the total
protein. Our data support this contention. However, their data also
indicate that unlike serum protein levels, amniotic fluid contains a
higher concentration of globulin than albumin until the 21st day of
gestation. The results obtained in our protein fractions studies are
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considerably different. From 13-1/2 to 20-1/2 days of gestation the
albumin fractions are always greater than the globulin fractions.
Marsh et al. (1960) reported that from 18 to 22 days of gestation in
the rat, the albumin fraction did not exceed 28.6% and that the alpha
globulin fraction represented from 51 to 68.8% of the total protein.
Our data suggest that in amniotic fluid albumin is continuously
being synthesized, although at different rates during the gestation
period. The large amounts of prealbumin observed on 13-1/2, 15-1/2,
19-1/2, and 20-1/2 days of gestation probably represents Increased
turnover rates for albumin, possibly due to the many biochemical and
physiological changes that occur in the fetuses and/or amnion itself
during these periods. According to Kelsey (1971), albumin is import¬
ant as a nutritional factor in tissue protein metabolism. Its most
important function is stabilization and regulation of intravascular
and extravascular fluid exchange under normal vascular conditions.
Albumin acts as a vehicle for the transport of many cations, asKtiwiS:,
and pigments. It also contributes to their excretion, solubilization,
stabilization and diffusion into tissues. Furthermore, albumin is
important in the stabilization and/or solubilization of the relatively
Insoluble globulins.
The highest mean alpha globulins that we obtained during our
entire study of amniotic fluid were 21% (cellulose acetate electro¬
phoresis) and 18.3% (gel electrophoresis). We also noted a trend of
decreasing concentration in the alpha globulin fraction. Marsh et al.
(1960) found the lowest concentration for the alpha globulin fraction
to be 51% at 20 days of gestation. They also noted a decreasing trend
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in the alpha globulin fraction as gestation advanced (18-22 days).
These workers surmised that the high percent of alpha globulin that
they obtained in their studies probably could be attributed to the
increased viscosity of rat amniotic fluid from 18-22 days of gestation.
In our sequential studies we, too, observed empirically that as gesta¬
tional days Increased, so did the relative viscosity of the amniotic
fluid. This statement is made on the basis of ease or difficulty
involved in amniotic fluid extraction. But from our data we cannot
postulate that albumin or alpha globulin are responsible for this
increased viscosity. One main detractant to this postulation is that
on 13-1/2 days of gestation, the albumin mean fraction is 61.8% and
the alpha fraction is 18.5% of the total protein. Subsequently, on
18-1/2 days of gestation we could readily observe an increase in the
relative viscosity of the amniotic fluid when the total albumin
fraction is 64% and alpha globulin fraction is 6.4% of the total
protein.
The beta fraction in the amniotic fluid Increased from 13-1/2 -
20-1/2 days of gestation except for a slight decrease on 17-1/2 and
18-1/2 days of gestation. However, even on 17-1/2 and 18-1/2 days of
gestation it was still higher than the beta fraction on 13-1/2 days of
gestation. There is a significant change in the beta fraction if you
compare 13-1/2 days with that of 19-1/2 and 20-1/2 days of gestation.
The graphic presentation of Wirtschafter and Williams (1957) showed
very little change in the absolute amounts of beta and gamma globulins
from 18 to 22 days of gestation. Marsh et al. (1964) also observed
that there was no decline in the percent of the two fractions. Our
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results from 18-1/2 - 20-1/2 days of gestation indicate that for the
beta globulin there is a gradual increase in its percentage. As for
the gamma globulin there is a slight decline in its concentration.
Our results show that the globulin fractions fluctuated during the
gestation period but not markedly.
In gravid human beings, the beta and gamma fractions have the
same concentration (11%) and the alpha fractions were 11.6% of the
total protein at term, according to McKay et al. (1955). Heron (1966)
reported that at 36 weeks of gestation in human beings the beta and
gamma fractions approximate each other in percent, but are not
necessarily the same. The percentages of the alpha fractions reported
by McKay et al (1958) , Heron (1956) , and Wirtschaf ter and Williams
(1957) are markedly less than reported by Marsh et. (1964).
The total protein in fetal serum exceeds that of the amniotic
fluid and it Increases as gestation increases. On the whole the
albumin fractions in the fetal serum are less than in amniotic fluid.
Prealbumin in fetal serum is lower than that of amniotic fluid from
13-1/2 to 16-1/2 days of gestation. This suggests that the turnover
of albumin is less in the fetal serum from 13-1/2 - 16-1/2 days of
gestation when compared with the turnover rate of albumin in the
amniotic fluid. From 17-1/2 - 20-1/2 days there are marked increases
in the prealbumin which could indicate that the turnover rate of
albumin increases as the fetuses mature. This implies that as the
fetuses progress toward term there is an increase in the irv situ physio¬
logical functions that the albumin controls or plays a regulatory role
in maintaining. Among the roles postulated could be stabilization of
63
blood volume and regulation of intravascular and extravascular fluid
exchanges; likewise, the transport of cations, anions and pigments
may be included.
The alpha fraction is lower in the fetal serum than in the
maternal serum. It approximates that found in normal serum. The
gamma fraction in the fetal serum was also found to be much lower than
that observed in non-pregnant and maternal rat serum. Longworth et al.
(1945) postulated that human fetal serum is much closer in composition
to non-pregnant female serum than maternal serum. The most noticeable
discrepancy was in the Increased proportion of gamma globulin in the
fetus, when compared with non-pregnant female serum. Our results
suggest that rat fetal serum proteins are closer in concentrations to
the amnlotic fluid than to those of maternal and non-pregnant rat
serum.
Sodium and Potassium Concentrations
In the maternal blood serum of the Long-Evans rat there is a
decreasing trend in the sodium concentration with gestational age of
in utero fetuses. The maternal serum sodium concentration is lower
than that of the non-pregnant rat serum. Sodium concentration in the
amniotic fluid from 13-1/2 - 14-1/2 days of gestation starts initially
at a decreased level and then at 15-1/2 days abruptly increases,
followed on days 16-1/2 to 19-1/2 by a conspicuous decrease and
increasing again on day 19-1/2. Noticeably at 19-1/2 and 20-1/2 days
the concentration of sodium is still not as high as it was on 15-1/2
days of gestation.
The observed decrease in the concentration of sodium in the
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fetal serum is very similar to that in the amniotic fluid. There is
a sharp increase at 15’-l/2 days of gestation; then there is a decrease
until 20-1/2 days. However, the concentration in the fetal serum
exceeds that of amniotic fluid during the same gestational period.
This low sodium concentration in the amniotic fluid may be caused by
the secretion of urine into the amniotic fluid by the fetus. According
to Lind (1973), the human fetal kidney starts functioning as early as
12 weeks of gestation or at the beginning of the second trimester. In
human maternal serum osmolality and sodium levels do not change with
increasing gestation. Also, there is a decreasing trend in the
osmolality and sodium concentrations in the amniotic fluid from 30-38
weeks of pregnancy (Lind and Cheyne, 1971; Battaglia et al., 1959).
The potassium levels of maternal rat serum and amniotic fluid
differ only slightly with advanced pregnancy, amniotic fluid had the
lowest concentration. This is in agreement with the work of Lind and
Cheyne (1971) in human beings. Our data show that the potassium levels
in the fetal serum greatly exceed those of maternal serum and amniotic
fluid.
The biochemical composition of amniotic fluid changes progress¬
ively as pregnancy advances. It could probably be that increasing
stratification of fetal skin Impedes and eventually prevents diffusion.
From then on the changing biochemical characteristics could reflect
the maturation of the fetal renal function and the activities of cells
that are found in the amniotic fluid. The biochemical and physiological
changes that occur in the fetus as gestation advances probably also have
some direct effect on the changes that occur in the amniotic fluid.
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Dimethylsulfoxide
Serum samples from maternal rat injected on day 14-1/2 of gesta¬
tion with DMSO and analyzed on 15-1/2 days of gestation reveal a drop
in the total protein concentration to 5.5 g/100 ml on the 15-1/2 days
of gestation, which is much lower than the total protein of untreated
rats on 15-1/2 days of gestation (7.04 g/100 ml). Subsequently, at
19-1/2 days of gestation the total protein concentration is the same
for the treated and untreated maternal rat serum. There were no
marked changes in the protein concentration of the amniotic fluid on
these days. The fact that DMSO did not cause a change in the total
protein on 19-1/2 days of gestation is probably due to the excretory
activities occurring in the rat's system. After 24 hrs dimethyl sul-
fone is excreted in the urine and dimethyl sulfide is eliminated in
the expired air (Wong et al. , 1971). Both of these substances are end
products of DMSO breakdown. This physiological activity allows the
maternal serum sample time for readjustment. On 15-1/2 days of gesta¬
tion, 24 hrs after the injection with DMSO, many of the biochemical and
physiological changes that occur upon the administration of DMSO were
observed because the limited time period did not allow for stabilization,
thus the observed increase in the total protein. It was suggested by
Williams et al. (1965) that because of its comparatively small size
DMSO was able to penetrate regions of the protein subunits interfaces
more readily than other bulkier solvents. Dimethylsulfoxide also
appears to be extremely effective in altering the configuration of
proteins and this change is apparently reversible after removal of DMSO
(Rammler, 1966).
6.16
The amniotic fluid protein fractions from fetuses of DMSO-treated
maternal rats (15-1/2 days) show marked increases in albumin fractions
and marked decrease in the alpha and gamma fractions when compared to
the untreated amniotic fluid. There is also an increase in the
albumin fractions and a decrease in the alpha and gamma fractions for
19-1/2 days but they are not as great as those for 15-1/2 days of
gestation. Thus, our data show that DMSO has a direct effect on the
protein levels in the amniotic fluid. This could occur by the absorp¬
tion of DMSO through the amniotic sac or by way of fetal secretions.
In man, after the administration of DMSO, relative amounts of DMS and
DMSO2 can be found in the plasma and urine, respectively (Wong et al.,
1971).
In fetal serum we noted a marked increase in the prealbumin
fraction on 15-1/2 days of gestation, and the albumin fraction is
almost the same as in untreated rats. The other fractions are very
similar in concentration to the normal. Fetal serum protein fraction
for 19-1/2 day fetuses of DMSO-treated maternal rats are very close
to the untreated. Here again, as in the maternal serum, it appears
that DMSO is affecting the levels of proteins more so 24 hrs after
injection in the 15-1/2-day fetuses than in the 19-1/2-day fetuses,
which is 96 hrs after injection of DMSO.
There are no significant changes in the sodium and potassium
levels in the DMSO-treated gravid females at 15-1/2 and 19-1/2 days
of gestation. However, in the amniotic fluid and fetal serum of
DMSO-treated rats for 15-1/2 and 19-1/2 days of gestation, there are
marked decreases in the sodium concentrations when compared to the
untreated rats (Table 16). The potassium levels are very close to
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those of the untreated rat. It appears that DMSO is causing electrolyte
disturbances in the fetal serum and amniotic fluid. These changes in
the fetal serum electrolytes could have a direct effect on the develop¬
ing fetus. Browne (1968, 1970) showed that these fluid and electrolyte
disturbances in embryonic and extra-embryonic compartments could lead
to induced anomalies in the chick embryo.
CHAPTER VI
SUMMARY AND CONCLUSIONS
The results of our overall investigation into the role of
macromolecules in the ontogeny of biochemical characterization and
maintenance of amniotic fluid show that:
1. During pregnancy the proteins of maternal serum, fetal
serum, and amniotic fluid are constantly changing. The total protein
concentration of non-pregnant serum is lower than that of pregnant
serum and the total protein concentration of amniotic fluid and fetal
serum increases as pregnancy advances in the rat-
2. The results of our Investigations did not support the idea
that the concentration of alpha globulin causes an increase in the
viscosity of the amniotic fluid with advancing gestation. This postu¬
lation is strikingly unfounded on the basis of no such marked increases
in the alpha globulins previously reported.
3. The amniotic fluid is more similar to the protein composition
of fetal serum than to the maternal serum from 13-1/2 - 20-1/2 days of
gestation in the rat.
4. The large amounts of prealbumin observed of amniotic fluid
and fetal serum suggest that the turnover rate in albumin in the
amniotic fluid and fetal serum is rapid, orderly, and possibly regulated.
5. Amniotic fluid has a larger concentration of albumin than
fetal serum as gestation advances. In both amniotic fluid and fetal




6. The sodium and potassium concentration of maternal serum
and amniotic fluid are very close during gestation. The sodium levels
gradually decline with advancing gestation.
7. In amniotic fluid and fetal serum there is a sharp increase
in the sodium concentration on 15-1/2 days of gestation, after which
there is a gradual decline. We suggest that this is due to the onset
of functions in the fetal kidney.
8. The potassium levels in fetal serum greatly exceed those of
maternal serum and amniotic fluid and this is probably due to the
dynamic biochemical and physiological changes that are occurring in
the developing fetus.
9. Twenty-four hours after the injection of DMSO into gravid
female rats, there is a significant decrease in the total protein of
maternal serum. The induction of DMSO into the rat's system can cause
the concentration of protein fractions to change. DMSO also causes
a decrease in sodium levels in fetal serum and amniotic fluid.
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